Trazodone: Difference between revisions
ClaireLewis (talk | contribs) |
Neil.m.young (talk | contribs) (Text replacement - "alpha" to "α") |
||
| Line 41: | Line 41: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
*Not well understood. May act like a SSRI. Also an | *Not well understood. May act like a SSRI. Also an α-1 adrenergic antagonist | ||
==Comments== | ==Comments== | ||
Revision as of 01:12, 24 July 2017
Administration
- Type: Antidepressant
- Dosage Forms:
- Routes of Administration: oral
- Common Trade Names:
Adult Dosing
- Insomnia: 50-100mg PO at bedtime
- Depression: 150-600 mg/day in divided doses
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing: no adjustment
- Hepatic dosing: no adjustment
Contraindications
- Allergy to class/drug
- MAOI use currently or in past 2 weeks
- Concomitant use of saquinavir/ritonavir
Adverse Reactions
Serious
- Prolonged QT, Torsades de pointes
- Hypotension
- Serotonin syndrome
- Suicidal thoughts/behavior
- Seizure
- Priapism
Common
- Somnolence, dizziness, confusion, insomnia, anxiety, dream disorder
- Headache, blurred vision
- Constipation, nausea/vomiting, xerostomia
- Backache
Pharmacology
- Half-life: 7h
- Metabolism: Hepatic, CYP3A4
- Excretion: Mostly renal
Mechanism of Action
- Not well understood. May act like a SSRI. Also an α-1 adrenergic antagonist